BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24170638)

  • 1. Psychopharmacological treatment for military posttraumatic stress disorder: an integrative review.
    Tawa J; Murphy S
    J Am Assoc Nurse Pract; 2013 Aug; 25(8):419-423. PubMed ID: 24170638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol use in the prevention and treatment of posttraumatic stress disorder in military veterans: forgetting therapy revisited.
    Donovan E
    Perspect Biol Med; 2010; 53(1):61-74. PubMed ID: 20173296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned?
    Bernardy NC; Friedman MJ
    Curr Psychiatry Rep; 2015 Apr; 17(4):564. PubMed ID: 25749751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review.
    Strawn JR; Keeshin BR; DelBello MP; Geracioti TD; Putnam FW
    J Clin Psychiatry; 2010 Jul; 71(7):932-41. PubMed ID: 20441729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant Symptoms.
    Spangler PT; West JC; Dempsey CL; Possemato K; Bartolanzo D; Aliaga P; Zarate C; Vythilingam M; Benedek DM
    J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33113596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for posttraumatic stress disorder at a Veterans Affairs facility.
    Kobayashi TM; Patel M; Lotito M
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S11-5. PubMed ID: 25991587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
    Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL
    J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment of combat-induced PTSD: a literature review.
    Bastien DL
    Br J Nurs; 2010 Mar 11-24; 19(5):318-21. PubMed ID: 20335903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of propranolol on posttraumatic stress disorder in burned service members.
    McGhee LL; Maani CV; Garza TH; Desocio PA; Gaylord KM; Black IH
    J Burn Care Res; 2009; 30(1):92-7. PubMed ID: 19060728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacotherapy of posttraumatic stress disorder.
    Kozaric-Kovacic D
    Croat Med J; 2008 Aug; 49(4):459-75. PubMed ID: 18716993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy as prophylactic treatment of post-traumatic stress disorder: a review of the literature.
    Roque AP
    Issues Ment Health Nurs; 2015; 36(9):740-51. PubMed ID: 26440879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Three paradigms in the treatment of posttraumatic stress disorder].
    Martényi F
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):11-21. PubMed ID: 16167463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
    Asnis GM; Kohn SR; Henderson M; Brown NL
    Drugs; 2004; 64(4):383-404. PubMed ID: 14969574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Selective Serotonin Reuptake Inhibitors on Healthcare Utilization in Patients with Post-Traumatic Stress Disorder and Alcohol Use Disorder.
    Naglich AC; Bozeman S; Brown ES; Adinoff B
    Alcohol Alcohol; 2019 Jul; 54(4):428-434. PubMed ID: 31185085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of psychotherapy dose and SSRI or SNRI refills with mental health outcomes among veterans with PTSD.
    Shin HJ; Greenbaum MA; Jain S; Rosen CS
    Psychiatr Serv; 2014 Oct; 65(10):1244-8. PubMed ID: 24981643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological blockade of memory reconsolidation in posttraumatic stress disorder: three negative psychophysiological studies.
    Wood NE; Rosasco ML; Suris AM; Spring JD; Marin MF; Lasko NB; Goetz JM; Fischer AM; Orr SP; Pitman RK
    Psychiatry Res; 2015 Jan; 225(1-2):31-39. PubMed ID: 25441015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting propranolol and PTSD: Memory erasure or extinction enhancement?
    Giustino TF; Fitzgerald PJ; Maren S
    Neurobiol Learn Mem; 2016 Apr; 130():26-33. PubMed ID: 26808441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatment of acute and chronic stress following trauma: 2006.
    Davidson JR
    J Clin Psychiatry; 2006; 67 Suppl 2():34-9. PubMed ID: 16602813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylaxis and therapy of post-traumatic stress disorder with propranolol: evidence and ethical analysis].
    Kühlmeyer K; Jox RJ
    Nervenarzt; 2013 Oct; 84(10):1183-9. PubMed ID: 24036701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors in post-traumatic stress disorder.
    Hidalgo RB; Davidson JR
    J Psychopharmacol; 2000 Mar; 14(1):70-6. PubMed ID: 10757257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.